路径导航: 首页

肿瘤内科代表性学术论文

来源:肿瘤内科
人阅读

1. Yuexian Wei§, Zubiao Niu§, Xinyu Hou§, Mengzhe Liu§, Yuqi Wang§, Yongan Zhou§, Chenxi Wang , Qunfeng Ma , Yichao Zhu , Xinyue Gao , Peiyun Li , Shuo Gao , Sibo Zhan , Zi Yang , Yanhong Tai , Qiuju Shao , Jianlin Ge , Jilei Hua , Lihua Gao , Qiang Sun *, Hong Jiang*, Hongyan Huang*. Subtype-based analysis of cell-in-cell structures in non-small cell lung cancer. Am J Cancer Res , 2023 Mar 15;13(3):1091-1102. eCollection 2023. (IF=5.942)

2. Su Yan§, Huang Hongyan§, Luo Tianzhi§, Zheng You, Fan Jie, Ren He, Tang Meng, Niu Zubiao, Wang Chenxi, Wang Yuqi, Zhang Zhengrong, Liang Jianqing, Ruan Banzhan, Gao Lihua, Chen Zhaolie, Melino Gerry, Wang Xiaoning, and Sun Qiang*. Cell-in-Cell Structure Mediates In-Cell Killing Suppressed by CD44. Cell Discov, 2022. 8(1): 35. DOI: 10.1038/s41421-022-00387-1 (IF=38.079)

3. Tang Meng§, Su Yan§, Zhao Wei§, Niu Zubiao§, Ruan Banzhan, Li Qinqin, Zheng You, Wang Chenxi, Zhou Yong, Zhang Bo, Zhou Fuxiang, Huang Hongyan*, Shi Hanping*, and Qiang Sun*. AIM-CICs: Automatic Identification Method for Cell-in-cell Structures based on Convolutional Neural Network. J Mol Cell Biol, 2022, DOI: 10.1093/jmcb/mjac044 (IF=8.185)

4. Shuo Wang§, Qi Shi§, Yuze Zhao§ , Yuguang Song, Guoliang Qiao*, Guangjie Liu , Qian Zhu, Lefu Huang, Chang Xu, Bing Liu , Zheng Chen , Hongyan Huang*. Expansion of CD3+CD8+PD1+ T lymphocytes and TCR repertoire diversity predict clinical responses to adoptive cell therapy in advanced gastric cancer. Am J Cancer Res, 2022 May 15;12(5):2203-2215. (IF=5.942)

5. Shuo Wang§, Yuze Zhao§, Yuguang Song§, Guoliang Qiao, Yan Di, Jing Zhao, Pingping Sun, Huixia Zheng, He Huang, Hongyan Huang*. ERBB2D16 Expression in HER2 Positive Gastric Cancer Is Associated With Resistance to Trastuzumab. Front Oncol, 2022. 12: 855308.DOI: 10.3389/fonc.2022.855308. (IF=5.738)

6. Zhang Zhengrong§, Zheng You§, Niu Zubiao§, Zhang Bo§, Wang Chenxi§, Yao Xiaohong§, Peng Haoran, Franca Del Nonno, Wang Yunyun, Zhu Yichao, Su Yan, Tang Meng, Jiang Xiaoyi, Ren He, He Meifang, Wang Yuqi, Gao Lihua, Zhao Ping, Shi Hanping, Chen Zhaolie, Wang Xiaoning, Piacentini Mauro, Bian Xiuwu, Melino Gerry, Liu Liang*, Huang Hongyan*, Sun Qiang*. SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination. Cell Death Differ, 2021 DOI: 10.1038/s41418-021-00782-3. (IF=12.067)

7. Liang Jianqing§, Niu Zubiao§, Zhang Bo§, Yu Xiaochen§, Zheng You, Wang Chenxi, Ren He, Wang Manna, Ruan Banzhan, Qin Hongquan, Zhang Xin, Zheng You, Gu Songzhi, Sai Xiaoyong, Tai Yanhong, Gao Lihua, Ma Li, Chen Zhaolie, Huang Hongyan*, Wang Xiaoning*, and Sun Qiang*. p53-dependent Elimination of Aneuploid Mitotic Offspring by Entosis. Cell Death Differ, 2021 DOI: 10.1038/s41418-020-00645-3. (IF=12.067)

8. Chen Jianxin§, Yang Fan§, Shi Qi, Zhao Yuze, and Huang Hongyan*. A Retrospective Study on Spinal Dissemination of Supratentorial Glioma. Front Oncol, 2021. 11: 765399.DOI: 10.3389/fonc.2021.765399. (IF=6.244)

9. Ren He, Ma Chaobing, Peng Haoran, Zhang Bo, Zhou Lulin, Su Yan, Gao Xiaoyan, and Huang Hongyan*. Micronucleus production, activation of DNA damage response and cGAS-STING signaling in syncytia induced by SARS-CoV-2 infection. Biology Direct, 2021. 16(1): 20.DOI: 10.1186/s13062-021-00305-7. (IF=7.137)

10. Chen Jianxin§, Zhao Yuze§, Hou Xinyu§, Gao Xiaoyan, Shi Qi, Li Shan, and Huang Hongyan*. Combined carboplatin and etoposide chemotherapy for patients with recurrent glioma. Ann Palliat Med, 2021. 10(12): 12650-12656.DOI: 10.21037/apm-21-3382. (IF=2.595)

11. Chen Jianxin§, Shi Qi§, Li Shan, Zhao Yuze, Huang Hongyan*. Clinical characteristics of glioblastoma with metastatic spinal dissemination. Ann Palliat Med, 2022. 11(2): 506-512.DOI: 10.21037/apm-21-3387. (IF=2.595)

12. Zubiao Niu§, Zhengrong Zhang§, Xiaoyan Gao§, Peng Du§, Jingjing Lu, Bohua Yan, Chenxi Wang, You Zheng, Hongyan Huang*, Qiang Sun*. N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding. Signal Transduct Target Ther, 2021. DOI: 10.1038/s41392-021-00704-2 (IF=38.104)

13. Chen Jianxin§, Shi Qi§, Li Shan, Zhao Yuze, and Huang Hongyan*. Characteristics of spinal dissemination in adult low-grade glioma: a retrospective cohort study at a single institute. Ann Palliat Med, 2021. 10(12): 12643-12649.DOI: 10.21037/apm-21-3390. (IF=2.595)

14. Wang Yuqi§, Niu Zubiao§, Zhou Lulin§, Zhou Yongan§, Ma Qunfeng§, Zhu Yichao, Liu Mengzhe, Shi Yinan, Tai Yanhong, Shao Qiuju, Ge Jianlin, Hua Jilei, Gao Lihua, Huang Hongyan*, Jiang Hong*, and Sun Qiang*. Subtype-Based Analysis of Cell-in-cell Structures in Esophageal Squamous Cell Carcinoma. Front Oncol, 2021. 11(2163) DOI: 10.3389/fonc.2021.670051. (IF=6.244)

15. Jiang Xiaoyi§, Zhang Zhengrong§, Wang Chenxi§, Ren Hongguang§, Gao Lihua§, Peng Haoran, Niu Zubiao, Ren He, Huang Hongyan*, Sun Qiang*. Bimodular effects of D614G mutation on the spike glycoprotein of SARS-CoV-2 enhance protein processing, membrane fusion and viral infectivity. Signal Transduct Target Ther, 2020. 5(1): 268-271. DOI: 10.1038/s41392-020-00392-4 (IF=18.187)

16. Huang Hongyan§*, He Meifang§, Zhang Yanbin§, Zhang Bo§, Niu Zubiao, Zheng You, Li Wen, Cui Peilin*, Wang Xiaoning*, Sun Qiang*. Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma. Signal Transduct Target Ther, 2020. 5(1): 246-248. DOI: 10.1038/s41392-020-00346-w. (IF=18.187)

17. Ruan, B§., Niu, Z§., Jiang, X§., Li, Z., Tai, Y., Huang Hongyan*, Sun Qiang *. High Frequency of Cell-in-Cell Formation in Heterogeneous Human Breast Cancer Tissue in a Patient With Poor Prognosis: A Case Report and Literature Review. Front Oncol, 2019. 9: 1-6. DOI. 10.3389/fonc.2019.01444 (IF=4.848)

18. Zhang Xin§, Niu Zubiao§, Qin Hongquan, Fan Jie, Wang Manna, Zhang Bo, Zheng You, Gao Lihua, Chen Zhaolie, Tai Yanhong*, Yang Mo*, Huang Hongyan*, and Sun Qiang*. Subtype-based Prognostic Analysis of Cell-in-Cell Structures in Early Breast Cancer. Front Oncol, 2019. 9: 1-12. DOI. 10.3389/fonc.2019.00895 (IF=4.848)

19. Huang Hongyan§, Chen Ang§, Wang Ting§, Wang Manna, Ning Xiangkai, He Meifang, Hu Yazhuo, Yuan Long, Li Shichong, Wang Qiwei, Liu Hong, Chen Zhaolie, Ren Jun*, and Sun Qiang*. Detecting cell-in-cell structures in human tumor samples by E-cadherin/CD68/CD45 triple staining. Oncotarget, 2015. 6(24): 20278-87. (IF=6.359)

20. Hongyan Huang, Zefei Jiang, Tao Wang, Shaohua Zhang, Li Bian, Yang Cao, Shikai Wu, Santai Song.Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer. Anti-Cancer Drugs. 2012 Aug;23(7):718-23. (IF=2.376)

21. Hongyan Huang, Ze-Fei Jiang, Qing-Xia Li, Jia-Yun Liu, Tao Wang, Rui Zhang, Jing Zhao, Yan-Ming Xu, Wei Bao, Yong Zhang, Lin-Tao Jia, An-Gang Yang. Inhibition of human breast cancer cell invasion by siRNA against urokinase-type plasminogen activator. Cancer invest. 2010 Aug;28(7): 689-97(IF=2.176)

22. 黄红艳张彦斌,王小利,周新娜,李莎,王嫚娜,任军. 靶向敲低核蛋白1抑制HepG2肝癌细胞的增殖及迁移. 细胞与分子免疫学杂志,2015,31(6):782-786

23. 黄红艳,王小利,周新娜,张彦斌,李莎,任军. 两种方法分离免疫细胞用于高通量测序TCR组库分析的比较.中华保健医学杂志,2015,17(3):215-218

24. 黄红艳,江泽飞,王涛,张少华,边莉,曹阳,吴世凯,宋三泰. 卡培他滨单药或联合方案治疗晚期乳腺癌的临床研究. 中华肿瘤杂志, 2011,33(11): 850-853

25. 黄红艳,江泽飞,王涛,张少华,边莉,曹阳,吴世凯,宋三泰. 贝伐珠单抗联合多西他赛治疗Her-2阴性复发转移性乳腺癌的疗效观察. 中国癌症杂志, 2011,21(3): 220-224

26. 黄红艳,江泽飞,新技术在乳腺癌诊治中的应用进展. 临床肿瘤学杂志, 2011,16(11): 1044-1047

27. 黄红艳,江泽飞,循环肿瘤细胞在乳腺癌中的研究进展. 国际肿瘤学杂志, 2011,38(7): 516-518

28. 黄红艳,江泽飞,卢新友,王涛,张少华. 术前新辅助治疗失败致不可切除乳腺癌2例. 中国实用外科杂志, 2010,30(9): 818-818

29. 黄红艳,江泽飞. 复发转移性乳腺癌分子靶向药物治疗进展. 中华乳腺病杂志(电子版),2010,(2):18-21

30. 黄红艳,王涛,江泽飞,申戈,边莉,张少华,吴世凯,宋三泰. AVASTIN联合泰索帝治疗HER2阳性晚期乳腺癌2例及文献回顾. 现代生物医学进展, 2009,(18): 3464-3466.

阅读全文